Key Takeaways
- Shares of ASML have surged 53% throughout 2026 and an impressive 120% over the trailing year, reaching record levels around $1,612
- First quarter 2026 earnings exceeded analyst forecasts with revenue growth of 13% and a 15% jump in operating income
- Morningstar has issued a Sell rating, noting shares trade at a 19% premium to their fair value calculation
- UBS analysts boosted their target price to €1,900, while the Street consensus maintains a “Moderate Buy” stance
- Proposed US legislation limiting chip manufacturing equipment exports to China poses a significant headwind
ASML shares began trading Friday at $1,612.76, hovering close to the 52-week peak of $1,654.20. This represents a substantial climb from the 52-week bottom of $683.48.
The Netherlands-based semiconductor equipment manufacturer has emerged as a standout performer in the artificial intelligence investment theme during 2026, posting year-to-date gains exceeding 53% and climbing 120% across the past year. The company’s valuation has reached $634 billion, securing its position as Europe’s largest publicly traded enterprise.
This extraordinary run has been driven by unprecedented appetite for cutting-edge semiconductor technology. ASML produces the sophisticated machinery that enables chip production — essentially providing the critical infrastructure for the entire semiconductor industry. Major clients include TSMC, Samsung Electronics, and Micron Technology.
First quarter 2026 financial performance exceeded Wall Street projections. Revenue increased 13% year-over-year, operating income advanced 15%, and gross margin reached 53%. Company leadership revised their full-year revenue guidance upward to a range of EUR 36–40 billion.
Morningstar equity analyst Javier Correonero enhanced his long-range forecast, now anticipating ASML could achieve EUR 60 billion in annual revenue by the end of the decade.
Street Sentiment Remains Constructive Despite Valuation Debates
The analyst community maintains a generally optimistic outlook. Among the firms monitored by MarketBeat, three assign a Strong Buy recommendation, twenty advocate Buy, six suggest Hold, and three recommend Sell. The average price target stands at $1,504.38 — modestly beneath current trading levels.
UBS elevated its price objective to €1,900 from €1,600 in recent days, maintaining its Buy recommendation. Barclays similarly upgraded shares to Buy on May 19. Both Deutsche Bank and Sanford C. Bernstein have reaffirmed their Buy ratings.
The primary contrarian perspective comes from Morningstar, which shifted ASML to Sell this week based on valuation considerations. At prevailing prices, shares command a 19% premium relative to Morningstar’s calculated fair value. The research firm acknowledges ASML’s formidable competitive advantages but highlights vulnerability to reduced capital expenditure by semiconductor manufacturers given the steep cost of its equipment.
ASML’s price-to-earnings multiple currently sits at 57.85, accompanied by a PEG ratio of 1.32. The 50-day moving average registers at $1,458.41.
Geopolitical Headwinds Loom Over Growth Trajectory
The regulatory environment introduces additional complexity. Pending US legislation could prohibit sales of ASML’s mid-range deep ultraviolet (DUV) systems to China — expanding beyond existing restrictions on advanced EUV technology already subject to export controls.
The Chinese market represents a significant revenue contributor for ASML’s DUV product portfolio. Elimination of this access would materially impact short-term financial performance.
Counterbalancing these concerns, ASML recently announced a strategic collaboration with Tata Electronics to facilitate India’s inaugural front-end semiconductor manufacturing facility — opening a promising new market opportunity.
Institutional capital has demonstrated continued accumulation. Consolidated Capital Management initiated a fresh $3.96 million stake during the fourth quarter. Multiple other institutional investors, including Founders Financial and Texas Yale Capital, expanded their holdings. Institutional ownership now comprises 26.07% of outstanding shares.
Most recently, ASML delivered earnings per share of $8.28 for the first quarter, accompanying quarterly revenue of $10.15 billion and achieving a net profit margin of 27.65%.
